Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2013-09-13

FDA Approved: SKYLA — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for SKYLA (levonorgestrel intrauterine system) submitted by Bayer HealthCare Pharmaceuticals Inc. to update the product …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SKYLA (LEVONORGESTREL)

Snippet

SUPPL AP for SKYLA (LEVONORGESTREL)